Medinova Diagnostic Services Inc Stock Price Today (NSE: MEDINOV)
Medinova Diagnostic Services Inc
Fundamental Score
Medinova Diagnostic Services Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Medinova Diagnostic Services Inc share price today is ₹43.45, up +0.00% on NSE/BSE as of 1 June 2026. Medinova Diagnostic Services Inc (MEDINOV) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹43.37 (Cr). The 52-week high for MEDINOV share price is ₹46.00 and the 52-week low is ₹37.10. At a P/E ratio of 20.17x, MEDINOV is currently trading below its industry average P/E of 39.28x.
Medinova Diagnostic Services Inc Share Price Chart — NSE/BSE Historical Performance
Medinova Diagnostic Services Inc share price chart: 7.28% return over the past month. 52-week high ₹46.00, 52-week low ₹37.10.
Medinova Diagnostic Services Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹44.89 | ₹44.89 | ₹41.25 | ₹43.45 | 37.83K (Cr) | |
| ₹44.00 | ₹45.10 | ₹43.51 | ₹44.01 | 43.98K (Cr) | |
| ₹43.86 | ₹44.78 | ₹43.70 | ₹44.03 | 44.80K (Cr) | |
| ₹44.40 | ₹44.99 | ₹44.00 | ₹44.22 | 9.88K (Cr) | |
| ₹44.05 | ₹44.50 | ₹43.85 | ₹44.29 | 8.46K (Cr) | |
| ₹43.10 | ₹45.00 | ₹43.10 | ₹44.54 | 15.40K (Cr) | |
| ₹43.80 | ₹44.77 | ₹43.30 | ₹43.81 | 6.56K (Cr) | |
| ₹42.10 | ₹43.40 | ₹42.10 | ₹43.30 | 6.15K (Cr) | |
| ₹42.79 | ₹43.19 | ₹41.63 | ₹42.69 | 5.29K (Cr) | |
| ₹44.00 | ₹44.00 | ₹42.13 | ₹42.79 | 4.47K (Cr) |
Medinova Diagnostic Services Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹39.48 | ₹45.10 | ₹38.90 | ₹43.45 | +10.06% | |
| ₹40.38 | ₹43.25 | ₹37.10 | ₹39.48 | -2.23% | |
| ₹40.85 | ₹43.90 | ₹38.60 | ₹40.18 | -1.64% | |
| ₹40.10 | ₹43.00 | ₹39.78 | ₹40.89 | +1.97% | |
| ₹39.70 | ₹46.00 | ₹39.21 | ₹41.02 | +3.32% | |
| ₹40.40 | ₹40.90 | ₹37.50 | ₹39.45 | -2.35% | |
| ₹39.45 | ₹40.25 | ₹38.30 | ₹39.85 | +1.01% |
AI Research Briefing
Powered by Gemini · 2026-04-08
Medinova is dead; long live Vijaya.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search.
CORE STORY (THE REAL GAME)
- Merger arbitrage play
- Acquisition by Vijaya Diagnostic Centre
- Scheme of amalgamation approved
- Vijaya's stock performance
- Regulatory approvals
- Change in merger terms
- Micro-cap illiquidity
- Merger completion risk (low probability)
- Limited upside
Promoter holding steady at 62.14%. No recent activity.
Healthcare sector in India is booming, but Medinova won't benefit directly.
Profit converting to cash, FCF 5Y at ₹8.22 Cr.
No future as an independent entity. Vijaya's outlook is the key.
Primary Thesis Risk
Merger falling through at this stage is highly unlikely, but still the biggest risk.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Medinova Diagnostic Services Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Medinova Diagnostic Services Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MEDINOV across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (108.87%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (27.35%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 20.17 vs Industry: 39.28)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Excellent EPS Growth (56.49% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (56.49% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (7.35x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (62.14%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Medinova Diagnostic Services Inc vs Healthcare Service Provider Peers
Peer Comparison - Healthcare Service Provider
Compare Medinova Diagnostic Services Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Medinova Diagnostic Services IncMedinova Diagno...Selected✓ MEDINOV • 526301 | 49/100 | ₹43.45₹43 | ₹43.37₹43.37 | 20.17Average 20.2 Average | — — | 108.87%Excellent 108.87% Excellent | — — | 56.49%Excellent 56.49% Excellent | 5.66%Good 5.66% Good | 0.00% |
Dr Lal PathLabs LtdDr Lal PathLabs... LALPATHLAB • 539524 | 64.3/100 | ₹1617.20₹1617 | ₹25557.40₹25557.40 | 47.83Average 47.8 Average | 24.30%Excellent 24.30% Excellent | 28.88%Excellent 28.88% Excellent | 0.07Excellent 0.1 Excellent | 16.69%Excellent 16.69% Excellent | 13.09%Good 13.09% Good | 0.79% |
Vijaya Diagnostic Centre LtdVijaya Diagnost... VIJAYA • 543350 | 53.7/100 | ₹1261.40₹1261 | ₹10272.45₹10272.45 | 67.39Average 67.4 Average | 19.00%Good 19.00% Good | 20.91%Excellent 20.91% Excellent | 0.42Excellent 0.4 Excellent | 18.97%Excellent 18.97% Excellent | 15.00%Excellent 15.00% Excellent | 0.20% |
Metropolis Healthcare LtdMetropolis Heal... METROPOLIS • 542650 | 48.9/100 | ₹536.15₹536 | ₹10124.28₹10124.28 | 63.98Average 64.0 Average | 11.53%Average 11.53% Average | 14.66%Average 14.66% Average | 0.14Excellent 0.1 Excellent | -0.56%Poor -0.56% Poor | 9.22%Good 9.22% Good | 0.20% |
Thyrocare Technologies LtdThyrocare Techn... THYROCARE • 539871 | 40.5/100 | ₹512.15₹512 | ₹7724.80₹7724.80 | 60.48Average 60.5 Average | 16.15%Good 16.15% Good | 24.78%Excellent 24.78% Excellent | 0.05Excellent 0.1 Excellent | -0.64%Poor -0.64% Poor | 9.62%Good 9.62% Good | 1.44% |
Krsnaa Diagnostics LtdKrsnaa Diagnost... KRSNAA • 543328 | 39.6/100 | ₹538.45₹538 | ₹2626.09₹2626.09 | 30.73Average 30.7 Average | 9.29%Poor 9.29% Poor | 12.52%Average 12.52% Average | 0.30Excellent 0.3 Excellent | 22.05%Excellent 22.05% Excellent | 21.41%Excellent 21.41% Excellent | 0.34% |
Suraksha Diagnostic LtdSuraksha Diagno... SURAKSHA • 544293 | 47.1/100 | ₹289.60₹290 | ₹1534.08₹1534.08 | 48.05Average 48.0 Average | 16.46%Good 16.46% Good | 17.84%Good 17.84% Good | 0.51Good 0.5 Good | 16.38%Excellent 16.38% Excellent | 9.86%Good 9.86% Good | 0.00% |
3B Blackbio Diagnostics Ltd3B Blackbio Dia... 3BBLACKBIO • 532067 | 66.1/100 | ₹1225.40₹1225 | ₹1080.56₹1080.56 | 22.01Average 22.0 Average | 19.40%Good 19.40% Good | 25.75%Excellent 25.75% Excellent | 0.00Excellent 0.0 Excellent | 44.03%Excellent 44.03% Excellent | 27.29%Excellent 27.29% Excellent | 0.32% |
One Global Service Provider IncOne Global Serv... ONEGLOBAL • 514330 | 69.5/100 | ₹424.15₹424 | ₹1070.08₹1070.08 | 24.39Average 24.4 Average | 42.31%Excellent 42.31% Excellent | 56.38%Excellent 56.38% Excellent | 0.00Excellent 0.0 Excellent | 128.82%Excellent 128.82% Excellent | — — | 0.00% |
Sastasundar Ventures LtdSastasundar Ven... SASTASUNDR • 533259 | 40.3/100 | ₹313.95₹314 | ₹1042.27₹1042.27 | — — | 4.63%Poor 4.63% Poor | -1.33%Poor -1.33% Poor | 0.01Excellent 0.0 Excellent | 23.31%Excellent 23.31% Excellent | 24.47%Excellent 24.47% Excellent | 0.00% |
46.5/100 | ₹233.90₹234 | ₹826.72₹826.72 | 30.47Average 30.5 Average | 27.08%Excellent 27.08% Excellent | 28.85%Excellent 28.85% Excellent | 0.48Excellent 0.5 Excellent | — — | — — | 0.00% | |
Top Healthcare Service Provider Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Dr Lal PathLabs Ltd share price25557.40 Cr
- Vijaya Diagnostic Centre Ltd share price10272.45 Cr
- Metropolis Healthcare Ltd share price10124.28 Cr
- Thyrocare Technologies Ltd share price7724.80 Cr
- Krsnaa Diagnostics Ltd share price2626.09 Cr
Medinova Diagnostic Services Inc PE Ratio History
Historical price-to-earnings ratio for MEDINOV — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹1.89 | ₹43.45 | 23x |
| FY 2024 | ₹2.00 | ₹37.25 | 18.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Medinova Diagnostic Services Inc Quarterly Performance
Latest quarterly metrics for MEDINOV — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-2.34%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
2.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
5.66%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
56.49%
Compounded annual net profit growth over 5 years
Medinova Diagnostic Services Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MEDINOV — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Medinova Diagnostic Services Inc Financial Statements
Annual income statement, balance sheet and cash flow for Medinova Diagnostic Services Inc (MEDINOV) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Medinova Diagnostic Services Inc
About MEDINOV (Medinova Diagnostic Services Inc)
Medinova Diagnostic Services Inc is a comprehensive healthcare service provider dedicated to delivering accurate and timely diagnostic information. Specializing in advanced medical... imaging and laboratory testing, MEDINOV leverages state-of-the-art technology to provide patients and physicians with critical insights for informed decision-making. Their commitment to quality extends to every facet of their operation, from stringent quality control measures in the lab to the meticulous attention to detail in image acquisition and interpretation. MEDINOV aims to be a trusted partner in healthcare, empowering individuals to proactively manage their health through early detection and precise diagnosis. The range of services offered by MEDINOV encompasses a broad spectrum of diagnostic modalities, including high-resolution MRI and CT scans for detailed anatomical visualization, digital X-ray for skeletal and pulmonary assessments, and advanced ultrasound techniques for real-time imaging. The facility also features a modern clinical laboratory performing comprehensive blood tests, including hematology, biochemistry, and microbiology analyses. Cardiac diagnostics are a key area of focus, with capabilities including ECG, echocardiography, and stress testing. The diagnostic services are supported by the experienced and certified healthcare professionals, and expert radiologists, ensuring that every test is performed and interpreted with the utmost precision. In addition to its extensive in-house capabilities, MEDINOV prioritizes patient convenience and accessibility through convenient services. The services include remote sample collection, facilitating laboratory testing from the comfort of one's own home. Moreover, quick report delivery ensures that patients and healthcare providers have access to results in a timely manner, supporting prompt medical intervention and treatment planning. Understanding the importance of accessibility, MEDINOV offers ambulance services for the transportation of patients who require medical assistance. The integration of advanced diagnostics, accessible support services and dedicated healthcare team underscores Medinova's dedication to providing high-quality, patient-centered care.
Company Details
Key Leadership
MEDINOV Share Price: Frequently Asked Questions
What is the current share price of Medinova Diagnostic Services Inc?
Medinova Diagnostic Services Inc (MEDINOV) trades at ₹43.45 on NSE and BSE. Market cap ₹43.37 (Cr). Educational data only.
What is the P/E ratio of Medinova Diagnostic Services Inc?
Medinova Diagnostic Services Inc has a P/E of 20.17x vs industry average 39.28x.
What is the Bull Run score for Medinova Diagnostic Services Inc?
Medinova Diagnostic Services Inc has a Bull Run score of 49/100 based on 25+ financial parameters.
Does Medinova Diagnostic Services Inc pay dividends?
Medinova Diagnostic Services Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Medinova Diagnostic Services Inc?
Medinova Diagnostic Services Inc has ROE of N/A. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Medinova Diagnostic Services Inc?
Medinova Diagnostic Services Inc has debt-to-equity of N/A.
Is Medinova Diagnostic Services Inc a good investment?
Bull Run gives Medinova Diagnostic Services Inc a score of 49/100. This is not investment advice — consult a SEBI-registered advisor.